The implantable cardioverter defibrillator (ICD) is able to reduce sudden arrhythmic death in
patients who are considered to be at high risk. However, the arrhythmic risk may be …

Although implantable cardioverter defibrillators (ICDs) have been well established to reduce
the risk of sudden cardiac death (SCD) in high-risk patients, there remain situations of …

Background The wearable cardioverter-defibrillator (WCD) is used for temporary protection
of patients deemed to be at high risk for sudden death (SCD) not yet meeting indications for …

Background: This study evaluated the wearable cardioverter-defibrillator (WCD) for use and
effectiveness in preventing sudden death caused by ventricular tachyarrhythmia or …

Sudden cardiac death (SCD) accounts for> 300 000 deaths in the United States annually. 1
Although the majority of these deaths occur in low-risk populations2 in which aggressive …

The benefit of implantable cardioverter-defibrillator (ICD) therapy depends upon appropriate
evaluation of a persisting risk of sudden death and estimation of the patient's overall …

Background—Prospective data on the safety and efficacy of the wearable cardioverter
defibrillator (WCD) in a real-world setting are lacking. The Prospective Registry of Patients …

Background: Wearable cardioverter-defibrillators (WCD) have been available in Japan since
April 2014, but their application is still limited. Methods and Results: We report 9 patients …

Background: The wearable cardioverter-defibrillator (WCD) is available for patients at high
risk for sudden cardiac death (SCD) when immediate implantable cardioverter-defibrillator …

Aims We aimed to provide contemporary real-world data on wearable cardioverter-
defibrillator (WCD) use, not only in terms of effectiveness and safety but also compliance …